GlassScriptPhysician profile
Craig L Bissinger
NPI 1083607865
$9,636.87
in general payments reported to CMS, 2019-2025
17 companies · $24.68 in 2025
The $24.68 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,968 · 2020: $2,829 · 2021: $2,188 · 2022: $1,354 · 2023: $185 · 2024: $88.23 · 2025: $24.68.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $298.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $298.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celularity INC. | $9,006.21 | 2019-2022 | |
| Astellas Pharma US INC | $98.80 | 2019-2023 | Myrbetriq, Veozah |
| Hologic Sales and Service, LLC | $88.23 | 2024 | Fluent Fluid Management System |
| Bayer Healthcare Pharmaceuticals INC. | $60.91 | 2020-2025 | |
| Therapeuticsmd, INC. | $54.52 | 2019 | |
| Mayne Pharma Commercial LLC | $47.88 | 2021-2023 | |
| Allergan, INC. | $43.49 | 2019-2020 | |
| Abbvie INC. | $43.04 | 2022-2023 | Lo Loestrin Fe |
| Amag Pharmaceuticals, INC. | $34.99 | 2019-2020 | |
| Avion Pharmaceuticals | $28.45 | 2022-2023 | Balcoltra |
| Pfizer INC. | $27.55 | 2020-2022 | |
| Vertical Pharmaceuticals, LLC | $26.32 | 2019 | |
| Exact Sciences Corporation | $24.83 | 2023 | Cologuard Collection Kit |
| Alydia Health | $24.12 | 2021 | |
| Evofem Biosciences, INC. | $13.93 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $13.60 | 2023 | Slynd |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Craig Bissinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.